Immediate Impact

2 by Nobel laureates 2 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
A foundation model for clinician-centered drug repurposing
2024 Standout
5 intermediate papers

Works of Nicolas Warin being referenced

Discovery of (R)-8-(1-(3,5-Difluorophenylamino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide (AZD8186): A Potent and Selective Inhibitor of PI3Kβ and PI3Kδ for the Treatment of PTEN-Deficient Cancers
2014
N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a Novel, Highly Selective, Orally Available, Dual-Specific c-Src/Abl Kinase Inhibitor
2006

Author Peers

Author Last Decade Papers Cites
Nicolas Warin 220 110 40 114 7 389
Lori K. Gavrin 215 125 24 67 9 378
Masaki Gouda 233 48 32 84 11 380
Henrik Moebitz 318 105 25 117 8 429
Amy M. Delaney 288 80 20 89 8 433
NICHOLAS B. LYDON 270 55 39 61 9 430
Aleksander Shavrin 243 26 24 128 6 434
Patricia Imbach‐Weese 304 92 82 68 6 429
Charles Watson Moore 205 163 41 154 9 442
Heidrun Hirner 270 37 23 156 11 404
Dominique R. Talbert 238 21 21 67 8 391

All Works

Loading papers...

Rankless by CCL
2026